In the past year, nearly a dozen companies have taken advantage of new rules to list on the Stock Exchange of Hong Kong Limited (HKEx). On April 30, 2018, HKEx introduced a series of reforms to encourage the listing of...more
6/19/2019
/ Biotechnology ,
China ,
Corporate Executives ,
Dual Class Share Structures ,
EU ,
Food and Drug Administration (FDA) ,
HKEx ,
Hong Kong Stock Exchange ,
Innovative Technology ,
Listing Rules ,
Patent Registration ,
Popular ,
Publicly-Traded Companies ,
Research and Development ,
Shareholders ,
Threshold Requirements ,
United States ,
Weighted Voting Rights (WVR)
After publishing the “New Board Concept Paper” in December 2017, the Stock Exchange of Hong Kong Limited (the Exchange) issued a consultation paper on February 23, 2018, titled “A Listing Regime for Companies From Emerging...more
4/26/2018
/ Biotechnology ,
China ,
Corporate Governance ,
Dual Class Share Structures ,
Emerging Technology Companies ,
Hong Kong ,
Hong Kong Stock Exchange ,
Initial Public Offering (IPO) ,
Innovation ,
Listing Rules ,
Publicly-Traded Companies ,
Research and Development ,
Secondary Listings ,
Shareholder Rights ,
Voting Rights
After publishing the “New Board Concept Paper Conclusions” in December 2017, the Stock Exchange of Hong Kong Limited (the Exchange) issued on 23 February 2018 a consultation paper entitled “A Listing Regime for Companies From...more
2/26/2018
/ Biotechnology ,
China ,
Corporate Governance ,
Dual Class Share Structures ,
Emerging Technology Companies ,
HKEx ,
Hong Kong ,
Hong Kong Stock Exchange ,
Innovation ,
Investor Protection ,
Issuer Eligibility Criteria ,
Listing Rules ,
Publicly-Traded Companies ,
Research and Development ,
Secondary Listings ,
Shareholder Rights ,
Technology Sector ,
Voting Rights ,
Waivers